🇪🇸 100% SPAIN STOCK·FAST 24-72H DISPATCHINDEPENDENT 99%+ PURITY102% MINIMUM FILL
The 4 most requested compounds · HPLC Purity ≥99%

Triple GLP-1 / GIP / GCGR Agonist

Dual GIP / GLP-1 Agonist

Regenerative Copper Tripeptide-1

Sterile USP Reconstitution



Simultaneously activates GIP and GLP-1 receptors in a biased manner, resulting in massive weight loss, superior metabolic control, and prolonged suppression of food cravings.
Condensed monograph drawn from preclinical literature, pharmacokinetics and clinical trials for tirzepatide.
Tirzepatide is a pioneer in incretin biology, serving as the first approved dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like pepti...
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. The literature shows that by targeting both receptors, it achieves synergistic effects on metabolic regulation, leading to unprecedented reductions in body weight and hemoglobin A1c in preclinical models.
Compare triple-receptor agonism (GLP-1/GIP/Glucagon) against dual incretin agonism, hepatic energy expenditure, EC50 affinities, and NEJM clinical trial benchmarks.
Technical reconstitution protocols, HPLC purity verification, storage conditions, and express European delivery details.
tirzepatide is brought into solution using the diluent specified on its technical datasheet: sterile bacteriostatic water or 0.9% NaCl. Insert the syringe and direct the stream gently against the inner vial wall. Swirl smoothly with circular motions rather than shaking vigorously, as mechanical agitation can shear delicate peptide chains. Once reconstituted, it remains stable refrigerated at 2–8 °C for up to 28 days.
At Iberia Labs, every batch of tirzepatide is verified by High-Performance Liquid Chromatography (HPLC) at ≥ 99.567% purity, with bacterial endotoxin levels strictly under 0.5 EU/mg and identity confirmed by Mass Spectrometry (MS). Each batch is backed by its lot-specific Certificate of Analysis (current lot: TIR-101626).
Lyophilized tirzepatide in vacuum-sealed vials should be stored at -20 °C, protected from light and moisture, with an unopened shelf life of 24 to 36 months. The sealed powder readily tolerates ambient temperature during transit without loss of potency. Upon receipt, transfer immediately to cold storage (-20 °C unopened, or 2–8 °C once reconstituted).
tirzepatide is available directly from Iberia Labs (iberialabs.eu), dispatched from warehouses within the European Union and Spain. Because shipments originate within the EU single market, orders are completely free from customs clearance delays. Orders dispatch within 24 hours, with 24–72 hour delivery in Spain and 2–5 business days across Europe.
Yes, tirzepatide may be legally purchased in Spain and throughout the European Union strictly for laboratory research, chemical analysis, and in-vitro or preclinical investigation (RUO). Iberia Labs supplies analytical-grade reagents exclusively to the scientific and research community. It is not an approved medicine and is not intended for human or animal consumption, nor for clinical diagnostics.
tirzepatide is available in individual vials (10 mg, 20 mg) starting at €44.95. Every order includes its verified lot-specific Certificate of Analysis at no extra cost. Prices are quoted in EUR and express shipping options are transparently calculated at checkout.
All confirmed orders of tirzepatide are dispatched within 24 business hours from our EU fulfillment facilities. Delivery across mainland Spain takes 24–72 hours via express courier. International European destinations arrive within 2–4 business days with secure and discreet packaging.
Yes. Every vial of tirzepatide is accompanied by an authentic Certificate of Analysis (CoA) for the current batch (TIR-101626). The report documents HPLC purity chromatograms, mass spectrometry identity validation, and endotoxin assays. You can view and download the full laboratory report directly in our Lab Report (CoA) section.
Tirzepatide is a dual agonist combining GIP and GLP-1 receptor stimulation, delivering superior glycemic control and weight reduction compared to single-receptor agonists like Semaglutide (GLP-1 only). Compared to Retatrutide (which adds a third agonist arm at the glucagon receptor), Tirzepatide features established regulatory approvals (Mounjaro/Zepbound) and extensive clinical documentation from the SURMOUNT trials. Read our full technical comparison on the Retatrutide vs Tirzepatide comparison page.